What is compassionate use?
In the medical community, where a drug that has not yet been approved for use is given an incurably patient patient who has no other alternatives to treatment, it is known as compassionate use. The idea of compassionate use is that the patient may die before the drug approval, and if he has a chance to save the patient's life, it prevails over potential risks. Many nations have compassionate use programs that reflect the desire of patients with diseases such as cancer and AIDS to access drugs that could treat their conditions.
There are several different ways to organize compassionate use. In general, compassionate use is permitted in the late stages of drug testing, after the basic tests have been used to confirm that the drug is not deadly or completely unnecessary. However, this does not mean that the drug is harmless because there may be serious side effects that have not yet been revealed in the test process, and the dosing level is also Usually is not known because it is still in the test phaseof it.
Some nations have what is known as the programs of the extended approach (EAP) or the treatment of new drugs (Indian treatment). Drug companies can apply for these programs so that patients who are not allowed in clinical trials have access to society drugs. In the EAP or Indian treatment program, doctors relate to their patients, and if patients meet the requirements, they will be allowed to access drugs. Some nations require drug companies to provide free treatment or at low costs in EAP/Indian programs.
In other cases, the drug society may indicate that it is willing to provide patients with access to their drugs as part of a compassionate use program, but does not have a formally organized program of extended access. In these cases, doctors apply to a regulatory agency that is responsible for the approval of a flying sale and the patient's case is reviewed by an official whoIt decides to grant or not or not grant a request for compassion. The turnover process in these cases may be less than 24 hours for urgent applications.
Sometimes the doctor recommends a compassionate application in the patient, suggesting that new drugs could be useful. In other cases, patients approach their doctors to discuss compassionate use after learning about the new drug release. If the patient and the physician agree, the doctor is responsible for sending the application and distribution of drugs. If drugs are not provided free of charge, patients should be aware that insurance companies usually do not cover compassionate use.
Compassionable use is certainly the possibility to consider people who have exhausted all other treatment options. However, patients should be aware that it can be very dangerous, and drug companies usually insist on surrendering to responsibility before the provision of drugstores, which clearly shows that patients take medicines at their own risk. Compassionate use should bediscussed with a doctor and close to any decision.